home / stock / ckpt / ckpt articles

CKPT Articles, Checkpoint Therapeutics Inc. - From 12/22/23

Stock Information
Company Name: Checkpoint Therapeutics Inc.
Stock Symbol: CKPT
Market: NASDAQ
Website: checkpointtx.com
Menu
CKPT CKPT Quote CKPT Short CKPT News CKPT Articles CKPT Message Board
Get CKPT Alerts

News, Short Squeeze, Breakout and More Instantly...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Checkpoint Therapeutics, Inc. - CKPT | Benzinga

NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of Checkpoint Therapeutics, Inc. ("Checkpoint" or t...
Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga

Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to ...

Nasdaq Gains 100 Points; Biomerica Shares Spike Higher | Benzinga

U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining over 100 points on Monday. The Dow traded up 0.01% to...

Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga

Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline...
Crude Oil Rises 3%; US Housing Market Index Increases In December | Benzinga

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 50 points on Monday. The Dow traded up 0.14% to 37,356.29...

Dow Gains Over 50 Points; Nippon Steel To Acquire U. S. Steel | Benzinga

U.S. stocks traded higher this morning, with the Dow Jones index gaining around 50 points on Monday. Following the market opening Monday, the Dow t...

What's Going On With Checkpoint Therapeutics (CKPT) Stock Nosediving? | Benzinga

Checkpoint Therapeutics Inc (NASDAQ: CKPT) shares are trading lower by 52.7% to $1.57 Monday morning after the company received a complete res...
Checkpoint Therapeutics Strengthens Intellectual Property Protection for Cosibelimab with New U.S. Patent Issuance | Benzinga

Upcoming PDUFA goal date of January 3, 2024 U.S. patent protection for cosibelimab through at least May 2038 WALTHAM, Mass., Dec. 05, 2023 (GLOB...

Checkpoint Therapeutics Announces Exercise of Warrants for $11.13 Million in Gross Proceeds | Benzinga

WALTHAM, Mass., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), a clinical-stage immunotherapy and...

Checkpoint Therapeutics to Participate in the Cantor Global Healthcare Conference | Benzinga

WALTHAM, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), a clinical-stage immunotherapy an...
Previous 10 Next 10